| 5135 |
Centers for Disease Control and Prevention |
Html |
en |
Alabama Activities to Prevent HAIs |
null |
| MPEG | 0.26842 |
| funding | 0.453474 |
| monthly update | 0.797202 |
| email address | 0.964024 |
| different file formats | 0.706107 |
| Affordable Care Act | 0.730645 |
| Epidemiology | 0.373381 |
| recent work | 0.761653 |
|
| PDF | 0.255271 |
| infectious disease | 0.824746 |
| PPT | 0.285468 |
| Laboratory Capacity | 0.815189 |
| Infectious Diseases | 0.842388 |
| DOC | 0.265636 |
| page | 0.32719 |
| ELC | 0.421752 |
|
CLICK HERE |
| 5703 |
Centers for Disease Control and Prevention |
Html |
en |
2-Nitropropane - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7600 |
Centers for Disease Control and Prevention |
Html |
en |
Tuberculosis Fact Series - TB Can be Treated |
Centers for Disease Control and Prevention, Division of Tuberculosis Elimination |
| latent TB infection | 0.504019 |
| treatment | 0.219032 |
| sings | 0.209876 |
| flem | 0.209545 |
| TB skin test | 0.41375 |
| TB disease | 0.904839 |
| air | 0.219271 |
| laughs | 0.210305 |
| kidneys | 0.210066 |
| body | 0.260634 |
| testing material | 0.240684 |
| local health department | 0.271035 |
| care provider instructs | 0.267546 |
| small needle | 0.240509 |
| Phlegm | 0.209669 |
| lungs | 0.318994 |
| blood test measures | 0.265222 |
| TB blood test | 0.476661 |
| TB infection | 0.525211 |
| health care | 0.274946 |
| health care worker | 0.267055 |
| chest | 0.208227 |
|
| cases | 0.208315 |
| reaction | 0.208067 |
| drugs | 0.232779 |
| tuberculosis | 0.210499 |
| medicine | 0.24109 |
| spine | 0.208609 |
| sick person | 0.251534 |
| brain | 0.208911 |
| people | 0.226451 |
| sneezes | 0.209775 |
| doctor | 0.226881 |
| symptoms | 0.2253 |
| inactive germs | 0.301012 |
| tests | 0.226575 |
| laboratory | 0.2081 |
| spread TB germs | 0.450059 |
| speaks | 0.209372 |
| parts | 0.208927 |
| tuberculin | 0.2084 |
| time | 0.208835 |
| TB germs | 0.683552 |
|
CLICK HERE |
| 8745 |
Centers for Disease Control and Prevention |
Html |
en |
CDC - Preventing Chronic Disease: Issue Archive |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. The mission of PCD is to promote the open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| mental health clients | 0.699202 |
| mental health | 0.762958 |
| health care provider | 0.696247 |
| Reproductive Health Surveillance | 0.688223 |
| Risk Factor Surveillance | 0.69869 |
| cover | 0.775273 |
| Workplace health promotion | 0.691513 |
| chronic disease practice | 0.680483 |
| state health departments | 0.709865 |
| population health | 0.715267 |
| health messages | 0.673914 |
| county health data | 0.690714 |
| us-mexico border region | 0.715146 |
| state health programs | 0.690257 |
| Evidence-Based Health | 0.681592 |
| public health practice | 0.698516 |
| community health | 0.819905 |
| Volume | 0.782185 |
| chronic disease | 0.850784 |
| Italian Behavioral Risk | 0.701078 |
| Worksite health promotion | 0.700286 |
| Community Voices | 0.674115 |
| Behavioral Risk Factor | 0.698766 |
| Health Status | 0.669924 |
| chronic disease prevention | 0.752174 |
|
| Evaluate Community Resources | 0.673561 |
| community health promotion | 0.707304 |
| chronic kidney disease | 0.706125 |
| multiunit housing providers | 0.702128 |
| Filipino child health | 0.686948 |
| Mental Health Program | 0.696362 |
| health promotion | 0.723545 |
| Special focus | 0.96669 |
| Community health coalitions | 0.70117 |
| Action Toward Community | 0.682816 |
| public health | 0.755608 |
| population health improvement | 0.697132 |
| Lay health advisors | 0.683895 |
| community-based obesity prevention | 0.671642 |
| health education program | 0.704565 |
| chronic disease programs | 0.675968 |
| high school students | 0.695371 |
| View | 0.77532 |
| States-Mexico border health | 0.685051 |
| physical activity | 0.795865 |
| health communications | 0.67329 |
| print | 0.775297 |
| older adults | 0.680322 |
| Public health workforce | 0.687987 |
|
CLICK HERE |
| 10054 |
Centers for Disease Control and Prevention |
Html |
en |
Investigational Use of Intravenous Zanamivir for 2013-2014 Influenza Season |
Information about intravenous influenza antiviral medications and CDC considerations related to investigational use of intravenous zanamivir for the 2015-2016 influenza season - CDC |
| pandemic influenza A. | 0.446587 |
| U.S. influenza | 0.43195 |
| infectious diseases | 0.765572 |
| critically ill patients | 0.481259 |
| neuraminidase inhibitor oseltamivir | 0.48097 |
| pandemic influenza A* | 0.441559 |
| 2014-2015 influenza season | 0.450025 |
| Oral oseltamivir treatment | 0.445087 |
| severe influenza | 0.506401 |
| oseltamivir treatment | 0.494475 |
| late oseltamivir treatment | 0.429562 |
| experimental human influenza | 0.460956 |
| Oseltamivir-resistant novel influenza | 0.436077 |
| Clinical infectious diseases | 0.64028 |
| Infectious Diseases Society | 0.646282 |
| New England journal | 0.47095 |
| Influenza Antiviral Medications | 0.483617 |
| seasonal influenza | 0.493022 |
| Lancet infectious diseases | 0.436574 |
| acute uncomplicated influenza | 0.446693 |
| Influenza Viruses | 0.435837 |
| influenza virus infections | 0.424519 |
| infectious disease journal | 0.466721 |
| influenza A H1N1 | 0.614584 |
| 2009 pandemic | 0.429598 |
|
| zanamivir | 0.442096 |
| influenza | 0.679884 |
| severe influenza infection | 0.432367 |
| prolonged influenza | 0.431269 |
| pandemic influenza | 0.562527 |
| oral oseltamivir | 0.479377 |
| oseltamivir carboxylate | 0.465426 |
| critically ill children | 0.444024 |
| extracorporeal membrane oxygenation | 0.489472 |
| Lipsitch M. Oseltamivir | 0.426793 |
| H1N1 influenza | 0.461022 |
| severe influenza disease | 0.44511 |
| uncomplicated influenza illness | 0.472012 |
| ill influenza patients | 0.480143 |
| Pediatric infectious disease | 0.457363 |
| previous influenza season | 0.449779 |
| oseltamivir resistance | 0.433857 |
| Influenza Study Group | 0.438731 |
| neuraminidase inhibitor | 0.514675 |
| official publication | 0.523349 |
| early oseltamivir treatment | 0.475002 |
| et al | 0.911917 |
| neuraminidase inhibitors—oral oseltamivir | 0.457106 |
| oseltamivir | 0.565381 |
|
CLICK HERE |
| 12406 |
Centers for Disease Control and Prevention |
Image |
null |
CDC Foundation Business Pulse: Flu Prevention (200W x 225H) |
null |
|
|
CLICK HERE |
| 12792 |
Centers for Disease Control and Prevention |
Html |
en |
When Do You Step In and Assist? Personal ProtectiveEquipment (PPE) | Ebola Hemorrhagic Fever | CDC |
null |
| hand signals | 0.558795 |
| certain steps | 0.615541 |
| healthcare provider | 0.966209 |
| doffing process | 0.805886 |
| unnecessary errors | 0.605804 |
| red flag words | 0.992464 |
|
| physical contact | 0.63181 |
| doffing assistant | 0.867653 |
| equipment | 0.263469 |
| assistance | 0.509497 |
| proper protocols | 0.589828 |
|
CLICK HERE |
| 13041 |
Centers for Disease Control and Prevention |
Html |
en |
Ebola in West Africa: The Importance of "Getting to Zero" |
One year after the Centers for Disease Control and Prevention began the largest international emergency response in agency history, the goal is the same: Get to zero new Ebola cases in West Africa. |
| date | 0.222778 |
| digital press kit | 0.445348 |
| new Ebola case | 0.527751 |
| M.D. | 0.221093 |
| governments | 0.219301 |
| danger | 0.222246 |
| hope | 0.2211 |
| international partners | 0.311922 |
| identification | 0.233229 |
| Disease Control | 0.336367 |
| important progress | 0.329703 |
| outbreak | 0.224648 |
| public health systems | 0.400064 |
| goal | 0.223129 |
| CDC Director Tom | 0.532211 |
| work | 0.222757 |
| public health officials | 0.41356 |
| travelers | 0.241499 |
| dramatic decrease | 0.338752 |
| airport | 0.219771 |
| steady decrease | 0.329489 |
| Guinea highlight | 0.313651 |
| Columbia | 0.219317 |
| largest international emergency | 0.44563 |
| agency history | 0.335918 |
|
| outbreaks | 0.222359 |
| new cases | 0.311549 |
| region | 0.239652 |
| District | 0.21933 |
| Link | 0.220284 |
| CDC teams | 0.418237 |
| United States | 0.313339 |
| arrival | 0.221809 |
| Sierra Leone | 0.439752 |
| Prevention | 0.223213 |
| signs | 0.221113 |
| world | 0.220535 |
| M.P.H | 0.231223 |
| public health | 0.41925 |
| Zero | 0.235911 |
| new Ebola cases | 0.77797 |
| Ebola treatment centers | 0.536421 |
| Liberia | 0.34785 |
| state health partners | 0.40608 |
| West Africa | 0.955918 |
| response | 0.245104 |
| Frieden | 0.233119 |
| CDC chronicles progress | 0.561414 |
| facilities | 0.219367 |
|
CLICK HERE |
| 13126 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Infant Botulism Caused by Clostridiumbaratii Type F - Iowa, 2013 |
Amaran Moodley, MD1, Patricia Quinlisk, MD2, Ann Garvey, DVM2, Nicholas Kalas, MPH2, Jason R. Barash3, Jessica M. Khouri, MD3 (Author affiliations at end of text). |
| Jason R. Barash | 0.511858 |
| new onset floppiness | 0.480028 |
| 2-week follow-up examination | 0.477305 |
| BAT administration | 0.430179 |
| fluid bacterial cultures | 0.467248 |
| progressive respiratory failure | 0.470406 |
| preliminary stool studies | 0.521471 |
| C. baratii | 0.696885 |
| cerebrospinal fluid studies | 0.494344 |
| infant botulism types | 0.727541 |
| infant botulism | 0.934152 |
| type F botulism | 0.581833 |
| Botulism Immune Globulin | 0.671154 |
| health care providers | 0.480244 |
| Nicholas Kalas | 0.418702 |
| botulinum toxin | 0.525395 |
| stool culture | 0.433649 |
| normal pupillary responses | 0.484853 |
| equine-derived botulism antitoxin | 0.65624 |
| excessive crying | 0.412773 |
| baratii infant botulism | 0.768085 |
| normal bowel movements | 0.479472 |
| Acute Disease Prevention | 0.471061 |
| vacuum cleaner bag | 0.463032 |
|
| C. botulinum | 0.432781 |
| Patricia Quinlisk | 0.420194 |
| oral feedings | 0.412332 |
| C. baratii type | 0.57279 |
| hospital emergency department | 0.544015 |
| magnetic resonance imaging | 0.476945 |
| Public Health | 0.458486 |
| rapid clinical improvement | 0.479073 |
| 3Infant Botulism Treatment | 0.632303 |
| United States | 0.489055 |
| classic risk factors | 0.467967 |
| 2-day history | 0.416552 |
| full-term pregnancy | 0.413385 |
| herpes simplex virus | 0.471524 |
| BAT treatment | 0.517957 |
| typical infant botulism | 0.678852 |
| Amaran Moodley | 0.503336 |
| Author affiliations | 0.411998 |
| ventilator support | 0.406346 |
| Iowa Department | 0.408273 |
| toxigenic C. baratii | 0.576586 |
| respiratory failure | 0.498645 |
| Clostridium baratii type | 0.610196 |
| Ann Garvey | 0.416432 |
|
CLICK HERE |
| 13257 |
Centers for Disease Control and Prevention |
Html |
en |
2009-10 State, Regional, and National Influenza Vaccination Report II |
FluVaxView 2009-10 State, Regional, and National Vaccination Report II - CDC |
| Microsoft PowerPoint file | 0.346591 |
| Early Vaccination Coverage | 0.457406 |
| influenza vaccination coverage | 0.498149 |
| Population Early Season | 0.493784 |
| Microsoft Word file | 0.347432 |
| Vaccination Trends | 0.441 |
| Women Vaccination Coverage | 0.52868 |
| Single Season Report | 0.379374 |
| Season Vaccination Coverage | 0.786328 |
| vaccination coverage | 0.965024 |
| Influenza Season Vaccination | 0.528269 |
| General Population Coverage | 0.475544 |
| hhs region | 0.349546 |
| Key Findings | 0.40274 |
| General Population | 0.791489 |
| 2011-12 Report | 0.361344 |
| National Immunization Survey-Flu | 0.347983 |
| Microsoft Excel file | 0.346305 |
| Live Birth Data | 0.34618 |
| Tweet Share Compartir | 0.350603 |
| Population Vaccination Coverage | 0.662003 |
| page options Skip | 0.355241 |
| different file formats | 0.34748 |
| Pregnant Women Vaccination | 0.526533 |
| Apple Quicktime file | 0.346665 |
|
| Season General Population | 0.580203 |
| General Population Vaccination | 0.665396 |
| (Flu) | 0.35602 |
| Behavioral Risk Factor | 0.346546 |
| Adobe PDF file | 0.34627 |
| 2012-13 Report | 0.361431 |
| Early Season Vaccination | 0.615584 |
| 2016-17 Trend Report | 0.400813 |
| Search Form Controls | 0.399308 |
| Health Care Personnel | 0.598433 |
| 2016-17 Key Findings | 0.35096 |
| 2016-17 Report | 0.362522 |
| NIS-Flu Influenza Data | 0.457541 |
| Local Areas | 0.388433 |
| General Population Place | 0.47699 |
| General Population NHIS | 0.475003 |
| level influenza vaccination | 0.461112 |
| Search Controls | 0.353702 |
| Mid-Season Flu Vaccination | 0.487798 |
| 2013-14 Report | 0.382475 |
| Vaccination Coverage Dashboard | 0.55595 |
| Download Report Data | 0.367552 |
| report | 0.443332 |
| Flu Vaccination Coverage | 0.562035 |
|
CLICK HERE |